Wells Fargo & Company C4 Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 25,761 shares of CCCC stock, worth $138,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,761
Previous 358 7095.81%
Holding current value
$138,594
Previous $2,000 5850.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$4.05 - $8.1 $102,882 - $205,764
25,403 Added 7095.81%
25,761 $119,000
Q1 2024

May 10, 2024
SELL
$5.3 - $11.0 $5,003 - $10,384
-944 Reduced 72.5%
358 $2,000
Q4 2023

Feb 09, 2024
BUY
$1.18 - $6.03 $1,142 - $5,837
968 Added 289.82%
1,302 $7,000
Q3 2023

Nov 13, 2023
BUY
$1.81 - $3.89 $41 - $89
23 Added 7.4%
334 $0
Q2 2023

Aug 15, 2023
SELL
$2.75 - $3.77 $19,734 - $27,053
-7,176 Reduced 95.85%
311 $0
Q1 2023

May 12, 2023
BUY
$3.1 - $9.02 $23,209 - $67,532
7,487 New
7,487 $23,000
Q3 2022

Nov 14, 2022
BUY
$8.03 - $12.77 $45,827 - $72,878
5,707 Added 1136.85%
6,209 $54,000
Q2 2022

Aug 12, 2022
SELL
$5.06 - $26.46 $92,506 - $483,741
-18,282 Reduced 97.33%
502 $4,000
Q1 2022

May 16, 2022
SELL
$19.99 - $33.23 $248,755 - $413,514
-12,444 Reduced 39.85%
18,784 $456,000
Q4 2021

Feb 14, 2022
BUY
$29.39 - $46.86 $83,820 - $133,644
2,852 Added 10.05%
31,228 $1.01 Million
Q3 2021

Nov 15, 2021
BUY
$35.91 - $50.5 $1.02 Million - $1.43 Million
28,341 Added 80974.29%
28,376 $1.27 Million
Q2 2021

Aug 16, 2021
SELL
$30.39 - $42.18 $159,365 - $221,191
-5,244 Reduced 99.34%
35 $0
Q1 2021

May 13, 2021
SELL
$31.96 - $46.5 $1.06 Million - $1.55 Million
-33,248 Reduced 86.3%
5,279 $195,000
Q4 2020

Feb 09, 2021
BUY
$22.8 - $37.05 $878,415 - $1.43 Million
38,527 New
38,527 $1.28 Million

Others Institutions Holding CCCC

# of Institutions
120
Shares Held
53.8M
Call Options Held
331K
Put Options Held
145K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $263M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email